MojiaBio is an emerging SynBio company with its goal to revolutionize conventional chemical industry with advanced biomanufacturing. The company is growing rapidly, investing in its leadership, team, and technology, with support from some of the world renowned visionary investors. In 2020, it completed its $41M Series A round by Asian Green Fund (lead), Bits & Bites, Hillhouse and Richland. In 2022, it completed an $80M Series B round led by Temasek, Sento Investment, LYZZ Capital and existing investors. Leveraging cutting edge synthetic biotechnology, MojiaBio works at the interface between biology and chemistry to lead and drive disruptive changes to today's chemical industry, offering low carbon footprint and sustainable green chemical processes to meet humanity's current needs. To support the rapid growth of its global R&D organization and expansion of its translational R&D team in Shanghai, MojiaBio has an opening for the Director of Bioprocessing.
Reporting to the CTO, the Director of Bioprocessing will be a key member of the R&D core in Shanghai. The role will involve leading R&D projects, and will lead a team of biotechnologists to develop and scale up biobased chemical products, creating green and sustainable solutions for biomanufacturing. The ideal candidate has a passion for science and an interest in developing novel, disruptive technologies and platforms. The position will lead, mentor and grow MojiaBio's talented team.
Specifically, the Director of Bioprocessing will bring strong scientific capabilities related to bacterial and yeast fermentation technologies, biotransformation, bioprocess scale-up and technology transfer. This individual should be comfortable operating in a fast-paced, dynamic and innovative interdisciplinary environment.
MNCJobz.com will not be responsible for any payment made to a third-party. All Terms of Use are applicable.